Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma

This case series describes the kinetics of humoral deficiency in patients with relapsed refractory multiple myeloma treated with bispecific antibodies, the infectious complications, and response to COVID-19 immunization.

Detalles Bibliográficos
Autores principales: Hammons, Lindsay R., Szabo, Aniko, Janardan, Abhishek, Dhakal, Binod, Chhabra, Saurabh, D’Souza, Anita, Mohan, Meera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617177/
https://www.ncbi.nlm.nih.gov/pubmed/36306135
http://dx.doi.org/10.1001/jamanetworkopen.2022.38961
_version_ 1784820783816638464
author Hammons, Lindsay R.
Szabo, Aniko
Janardan, Abhishek
Dhakal, Binod
Chhabra, Saurabh
D’Souza, Anita
Mohan, Meera
author_facet Hammons, Lindsay R.
Szabo, Aniko
Janardan, Abhishek
Dhakal, Binod
Chhabra, Saurabh
D’Souza, Anita
Mohan, Meera
author_sort Hammons, Lindsay R.
collection PubMed
description This case series describes the kinetics of humoral deficiency in patients with relapsed refractory multiple myeloma treated with bispecific antibodies, the infectious complications, and response to COVID-19 immunization.
format Online
Article
Text
id pubmed-9617177
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-96171772022-11-29 Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma Hammons, Lindsay R. Szabo, Aniko Janardan, Abhishek Dhakal, Binod Chhabra, Saurabh D’Souza, Anita Mohan, Meera JAMA Netw Open Research Letter This case series describes the kinetics of humoral deficiency in patients with relapsed refractory multiple myeloma treated with bispecific antibodies, the infectious complications, and response to COVID-19 immunization. American Medical Association 2022-10-28 /pmc/articles/PMC9617177/ /pubmed/36306135 http://dx.doi.org/10.1001/jamanetworkopen.2022.38961 Text en Copyright 2022 Hammons LR et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Hammons, Lindsay R.
Szabo, Aniko
Janardan, Abhishek
Dhakal, Binod
Chhabra, Saurabh
D’Souza, Anita
Mohan, Meera
Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
title Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
title_full Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
title_fullStr Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
title_full_unstemmed Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
title_short Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
title_sort kinetics of humoral immunodeficiency with bispecific antibody therapy in relapsed refractory multiple myeloma
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617177/
https://www.ncbi.nlm.nih.gov/pubmed/36306135
http://dx.doi.org/10.1001/jamanetworkopen.2022.38961
work_keys_str_mv AT hammonslindsayr kineticsofhumoralimmunodeficiencywithbispecificantibodytherapyinrelapsedrefractorymultiplemyeloma
AT szaboaniko kineticsofhumoralimmunodeficiencywithbispecificantibodytherapyinrelapsedrefractorymultiplemyeloma
AT janardanabhishek kineticsofhumoralimmunodeficiencywithbispecificantibodytherapyinrelapsedrefractorymultiplemyeloma
AT dhakalbinod kineticsofhumoralimmunodeficiencywithbispecificantibodytherapyinrelapsedrefractorymultiplemyeloma
AT chhabrasaurabh kineticsofhumoralimmunodeficiencywithbispecificantibodytherapyinrelapsedrefractorymultiplemyeloma
AT dsouzaanita kineticsofhumoralimmunodeficiencywithbispecificantibodytherapyinrelapsedrefractorymultiplemyeloma
AT mohanmeera kineticsofhumoralimmunodeficiencywithbispecificantibodytherapyinrelapsedrefractorymultiplemyeloma

Ejemplares similares